Evidence map›Paper›PMID 28473954›Full record

ArticleCurrent treatment options in rheumatology2016

Scleroderma Mimickers.

Nadia D Morgan, Laura K Hummers

Abstract read
In one paragraph

Article in Current treatment options in rheumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. A rare case of scleredema associated with breast cancer.Journal of scleroderma and related disorders · 2025
    Article
  4. Article
  5. Scleroderma and scleroderma-like syndromes.Frontiers in immunology · 2024
    Review
  6. Hair Disorders in Autoimmune Diseases.Skin appendage disorders · 2023
    Review
  7. Eosinophilic Fasciitis: Current and Remaining Challenges.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Atypical Dermatitis of the Hand: A Quiz.Acta dermato-venereologica · 2022
    Article
  10. Eosinophilic Fasciitis With a Malignant Outcome.Journal of medical cases · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. [Systemic sclerosis].Der Internist · 2019
    Review
  15. Article
  16. [Mimetics of systemic sclerosis].Zeitschrift fur Rheumatologie · 2019
    Review
  17. Diffuse skin thickening, myalgias and joint stiffness in a 41-year-old man.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nadia D MorganDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Laura K HummersDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Multidisciplinary Rheumatology Training ProgramT32AR048522 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLIFTON O BINGHAM, LIVIA A CASCIOLA-ROSEN · 2003 to 2026
$6.4M
NIAMS NIH HHS T32 AR048522
6 · The paper itself

Abstract

Cutaneous fibrosing disorders encompass a diverse array of diseases united by the presence of varying degrees of dermal sclerosis. The quality and distribution of skin involvement, presence or absence of systemic complications and unique associated laboratory abnormalities often help to distinguish between these diseases. It is imperative that an effort is made to accurately differentiate between scleroderma and its mimics, in order to guide long-term management and facilitate implementation of the appropriate treatment modality where indicated.

Indexed as

Eosinophilic fasciitisMorpheaNephrogenic systemic fibrosisScleredemaSclerodermaScleromyxedemaSystemic sclerosis

Identifiers

PMID28473954
PMCPMC5412724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.